Sarissa Capital Management LP - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Sarissa Capital Management LP ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$1,310,160
-31.4%
618,0000.0%0.18%
-7.4%
Q2 2023$1,909,620
-42.6%
618,0000.0%0.19%
-55.3%
Q1 2023$3,324,840
-19.1%
618,0000.0%0.42%
-13.1%
Q4 2022$4,109,700
+67.1%
618,0000.0%0.49%
+75.9%
Q3 2022$2,460,000
-19.9%
618,0000.0%0.28%
-10.0%
Q2 2022$3,071,000
-28.1%
618,000
-12.6%
0.31%
-23.5%
Q1 2022$4,270,000
-48.0%
707,0100.0%0.40%
-43.2%
Q4 2021$8,215,000
-25.9%
707,0100.0%0.71%
-18.3%
Q3 2021$11,086,000
-15.9%
707,0100.0%0.87%
-17.0%
Q2 2021$13,186,000
-56.7%
707,0100.0%1.05%
-64.1%
Q1 2021$30,472,000707,0102.92%
Other shareholders
VOR BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$73,923,00013.88%
RA Capital Management 11,120,973$129,226,0002.28%
Paradigm Biocapital Advisors LP 629,342$7,313,0002.09%
OUP Management Co., LLC 374,714$4,354,0001.96%
JOHNSON & JOHNSON 1,074,658$12,488,0001.42%
Sarissa Capital Management LP 707,010$8,215,0000.71%
Woodline Partners LP 1,111,123$12,911,0000.18%
Artal Group S.A. 550,000$6,391,0000.17%
Orbimed Advisors 833,333$9,683,0000.12%
Laurion Capital Management LP 857,308$9,962,0000.10%
View complete list of VOR BIOPHARMA INC shareholders